| Colombia | | |
New HIV infections (per 1000 uninfected population) | 0.18 (2020) [3/19countries] | | | Tuberculosis incidence (per 100,000 population) | 41.0 (2021) [2/38countries] | | | Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%) | 0.2 (2020) [13/38countries] | | | Probability of dying from any of CVD, cancer, diabetes, CRD between age 30-70 (%) | 9.7 (2019) [23/38countries] | | |
|
| Colombia | | |
Incidents of all cancers (age-standardized rate, per 100,000 population) | 182.3 (2020) [36/38countries] | | | Incidents of cancer at bladder (age-standardized rate, per 100,000 population) | 3.0 (2020) [36/38countries] | | | Incidents of cancer at brain, central nervous system (age-standardized rate, per 100,000 population) | 3.4 (2020) [34/38countries] | | | Incidents of cancer at breast (age-standardized rate, per 100,000 population) | 48.3 (2020) [34/38countries] | | | Incidents of cancer at cervix uteri (age-standardized rate, per 100,000 population) | 14.9 (2020) [7/38countries] | | | Incidents of cancer at colorectum (age-standardized rate, per 100,000 population) | 21.2 (2020) [37/38countries] | | | Incidents of cancer at corpus uteri (age-standardized rate, per 100,000 population) | 8.1 (2020) [35/38countries] | | | Incidents of cancer at gallbladder (age-standardized rate, per 100,000 population) | 1.1 (2020) [8/38countries] | | | Incidents of cancer at kidney (age-standardized rate, per 100,000 population) | 4.2 (2020) [37/38countries] | | | Incidents of cancer at larynx (age-standardized rate, per 100,000 population) | 1.6 (2020) [24/38countries] | | | Incidents of cancer at leukaemia (age-standardized rate, per 100,000 population) | 6.2 (2020) [32/38countries] | | | Incidents of cancer at lip and oral cavity (age-standardized rate, per 100,000 population) | 1.4 (2020) [35/38countries] | | | Incidents of cancer at liver (age-standardized rate, per 100,000 population) | 3.5 (2020) [33/38countries] | | | Incidents of cancer at lung (age-standardized rate, per 100,000 population) | 10.5 (2020) [36/38countries] | | | Incidents of cancer at skin (age-standardized rate, per 100,000 population) | 7.6 (2020) [35/38countries] | | | Incidents of cancer at multiple myeloma (age-standardized rate, per 100,000 population) | 2.2 (2020) [34/38countries] | | | Incidents of cancer at nasopharynx (age-standardized rate, per 100,000 population) | 0.3 (2020) [21/37countries] | | | Incidents of cancer at lymphoma (age-standardized rate, per 100,000 population) | 8.5 (2020) [33/38countries] | | | Incidents of cancer at oesophagus (age-standardized rate, per 100,000 population) | 1.3 (2020) [34/38countries] | | | Incidents of cancer at oropharynx (age-standardized rate, per 100,000 population) | 0.9 (2020) [30/38countries] | | | Incidents of cancer at ovary (age-standardized rate, per 100,000 population) | 7.5 (2020) [24/38countries] | | | Incidents of cancer at pancreas (age-standardized rate, per 100,000 population) | 4.1 (2020) [37/38countries] | | | Incidents of cancer at prostate (age-standardized rate, per 100,000 population) | 49.8 (2020) [33/38countries] | | | Incidents of cancer at stomach (age-standardized rate, per 100,000 population) | 12.8 (2020) [5/38countries] | | | Incidents of cancer at testis (age-standardized rate, per 100,000 population) | 4.8 (2020) [30/38countries] | | | Incidents of cancer at thyroid (age-standardized rate, per 100,000 population) | 9.1 (2020) [16/38countries] | | |
|
| Colombia | | |
Suicide, age-standardized (per 100 000 population) | 3.74 (2019) [36/38countries] | | | Suicide - male, age-standardized (per 100 000 population) | 5.96 (2019) [36/38countries] | | | Suicide - female, age-standardized (per 100 000 population) | 1.71 (2019) [36/38countries] | | | Suicide - 15-24 years (per 100,000 population) | 5.68 (2019) [27/38countries] | | | Suicide - 15-24 years, male (per 100,000 population) | 8.06 (2019) [28/38countries] | | | Suicide - 15-24 years, female (per 100,000 population) | 3.22 (2019) [20/38countries] | | | Suicide - 25-34 years (per 100,000 population) | 4.62 (2019) [35/38countries] | | | Suicide - 25-34 years, male (per 100,000 population) | 7.04 (2019) [35/38countries] | | | Suicide - 25-34 years, female (per 100,000 population) | 2.18 (2019) [33/38countries] | | | Suicide - 35-44 years (per 100,000 population) | 3.86 (2019) [37/38countries] | | | Suicide - 35-44 years, male (per 100,000 population) | 6.19 (2019) [37/38countries] | | | Suicide - 35-44 years, female (per 100,000 population) | 1.67 (2019) [36/38countries] | | | Suicide - 45-54 years (per 100,000 population) | 3.97 (2019) [37/38countries] | | | Suicide - 45-54 years, male (per 100,000 population) | 6.62 (2019) [37/38countries] | | | Suicide - 45-54 years, female (per 100,000 population) | 1.62 (2019) [37/38countries] | | | Suicide - 55-64 years (per 100,000 population) | 4.22 (2019) [37/38countries] | | | Suicide - 55-64 years, male (per 100,000 population) | 7.51 (2019) [37/38countries] | | | Suicide - 55-64 years, female (per 100,000 population) | 1.36 (2019) [37/38countries] | | | Suicide - 65-74 years (per 100,000 population) | 6.47 (2019) [35/38countries] | | | Suicide - 65-74 years, male (per 100,000 population) | 12.65 (2019) [33/38countries] | | | Suicide - 65-74 years, female (per 100,000 population) | 1.29 (2019) [37/38countries] | | | Suicide - 75-84 years (per 100,000 population) | 8.06 (2019) [31/38countries] | | | Suicide - 75-84 years, male (per 100,000 population) | 16.99 (2019) [31/38countries] | | | Suicide - 75-84 years, female (per 100,000 population) | 1.29 (2019) [36/38countries] | | | Suicide - 85 years and over (per 100,000 population) | 11.70 (2019) [30/38countries] | | |
|
| Colombia | | |
Density of medical doctors (per 10,000 population) | 23.6 (2013?2021) [37/38countries] | | | Density of nursing and midwifery personnel (per 10,000 population) | 14.5 (2013?2021) [38/38countries] | | | Density of dentists (per 10,000 population) | 8.3 (2013?2021) [17/38countries] | | | Density of pharmacists (per 10,000 population) | 1.7 (2013?2021) [37/37countries] | | | Hospital beds (number per 1,000 population) | 1.7 (2018) [36/38countries] | | | Health expenditure (% of GDP) | 8.1% (2022) [26/38countries] | | | Population with household expenditures on health > 10% of total household expenditure or income (%) | 8.2 (2013?2021) [9/23countries] | | |
|
|